. . . . . . . . "Cangene Corporation"@en . . . . . . . . "in Winnipeg, Manitoba, Canada"@en . . . . "Cangene Corporation was a biopharmaceutical company based in Winnipeg, Manitoba, Canada. It was founded in 1984 and specialized in hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense. Cangene was 61% owned by Canadian pharmaceutical giant Apotex and was publicly listed on the TSX under the symbol CNJ."@en . . . . . . . . . . . . . . . . . "Cangene Corporation"@en . . . . . . "Acquired by Emergent BioSolutions"@en . . . "10949"^^ . . . . . . . . . . . . . . "pharmaceutical industry; contract manufacturing industry"@en . "1984"^^ . . "3660697"^^ . . . . . . . "Acquired byEmergent BioSolutions"@en . . . . . . "Cangene bioPharma"@en . . . . . "Cangene Corporation was a biopharmaceutical company based in Winnipeg, Manitoba, Canada. It was founded in 1984 and specialized in hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense. Cangene was 61% owned by Canadian pharmaceutical giant Apotex and was publicly listed on the TSX under the symbol CNJ."@en . . . . . . "1034140624"^^ . . "Cangene"@en . . . .